The relatively larger number of eGenes in these cancer types can not be explained by the mutation frequency of TP53 (Fig S18 in S3 Appendix) or genome-wide somatic mutation load (Fig S19 in S3 Appendix). This evidence concerns the gene TP53 and cancer.